Allurion, while battling declining revenues, is targeting the loss in muscle mass seen in patients on GLP-1RA therapy.
U.S. stock futures fell on Friday following a 25 basis point rate hike by the Bank of Japan. Futures of all four indices declined.
MIAMI, FL / ACCESS Newswire / January 24, 2025 / SMX PLC is solidifying its position as a pivotal partner in developing digital solutions that drive and manage a global circular economy. At the ...
Allurion Technologies (ALUR) stock climbed 200% despite a ~7.4M stock and warrants offering announced by the company. Read ...
Allurion stock soars on weight-loss therapy update. Stardust Power breaks ground on Oklahoma lithium refinery. OpenAI ...
Shares in the NYSE-listed company rose 77% at market open on 24 January 2025, compared to a market close, which occurred shortly after Allurion made the announcement. It is the highest price the ...
Allurion Technologies (NYSE: ALUR) shares are moving higher Friday potentially after after the company announced plans to ...
--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the ... The gross proceeds to the Company from this offering are expected to be approximately $7.4 million, before deducting the placement ...